IL22 and head and neck squamous cell carcinoma: Investigating the IL-22 functionality in a head and neck squamous cell carcinoma (HNSCC) model, a comparison of a second-generation CAR T cells with fourth-generation CAR-T cells merged with this cytokine (55) was done.